Size A A Color C C C C

Publications and Presentations


AAV Vectors




X-Linked Retinitis Pigmentosa


Visionary science for life changing cures.

AGTC is now pre-screening for a phase 2/3 clinical trial of an investigational gene therapy in people with X-Linked Retinitis Pigmentosa.

Learn more about the clinical trial or how to qualify for pre-screening: